AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
To address the preventive & primary healthcare delivery gaps in India
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
With the approval from the Central Drugs Standard Control Organisation (CDSCO), Jardiance is now the first approved therapy to improve outcomes for the full spectrum of heart failure regardless of ejection fraction
The drug will be manufactured at the group's formulation facility at SEZ, Ahmedabad
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
These melas serve as platforms to attract thousands of people to avail quality healthcare services along with essential medicines and diagnostic services
Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up
Subscribe To Our Newsletter & Stay Updated
